$PKE
PARK AEROSPACE CORP Stock $pke

$pke Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000143774922016868 Filed on July 08, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$13.88M	$12.78M	$12.50M
YoY Change	1.89%	-5.97%	-13.43%
Cost Of Revenue	$9.789M	$8.691M	$8.304M
YoY Change	6.32%	7.01%	-17.78%
Gross Profit	$4.086M	$4.092M	$4.198M
YoY Change	-7.37%	-25.22%	-2.96%
Gross Profit Margin	29.45%	32.01%	33.58%
Selling, General & Admin	$1.732M	$1.633M	$1.520M
YoY Change	16.4%	-0.91%	8.57%
% of Gross Profit	42.39%	39.91%	36.21%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$261.0K	$260.0K	$331.0K
YoY Change	11.06%	20.37%	18.21%
% of Gross Profit	6.39%	6.35%	7.88%
Operating Expenses	$1.732M	$1.633M	$1.520M
YoY Change	16.4%	-0.91%	8.57%
Operating Profit	$2.354M	$2.459M	$2.678M
YoY Change	-14.49%	-35.46%	-8.48%
Interest Expense	$221.0K	$133.0K	$89.00K
YoY Change	148.31%	13.68%	-55.5%
% of Operating Profit	9.39%	5.41%	3.32%
Other Income/Expense, Net
YoY Change
Pretax Income	$2.575M	$2.592M	$2.705M
YoY Change	-9.39%	-34.0%	69.06%
Income Tax	$690.0K	$682.0K	$749.0K
% Of Pretax Income	26.8%	26.31%	27.69%
Net Earnings	$1.885M	$1.910M	$1.956M
YoY Change	-6.78%	-30.42%	89.53%
Net Earnings / Revenue	13.59%	14.94%	15.65%
Basic Earnings Per Share	$0.09	$0.09	$0.10
Diluted Earnings Per Share	$0.09	$0.09	$0.10
COMMON SHARES
Basic Shares Outstanding	20.46M	20.46M	20.46M
Diluted Shares Outstanding	20.50M	20.50M	20.51M

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$102.5M	$107.3M	$110.4M
YoY Change	-9.2%	-8.12%	-5.27%
Cash & Equivalents	$3.836M	$4.333M	$12.81M
Short-Term Investments	$98.63M	$103.0M	$97.55M
Other Short-Term Assets	$3.967M	$3.862M	$3.082M
YoY Change	27.07%	11.1%	-9.35%
Inventory	$7.850M	$6.649M	$4.657M
Prepaid Expenses
Receivables	$9.950M	$8.957M	$8.339M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$124.2M	$126.8M	$126.4M
YoY Change	-3.89%	-4.65%	-4.46%
LONG-TERM ASSETS
Property, Plant & Equipment	$24.46M	$24.16M	$24.33M
YoY Change	5.36%	7.42%	15.16%
Goodwill			$9.776M
YoY Change			0.0%
Intangibles			$14.00K
YoY Change			-33.33%
Long-Term Investments
YoY Change
Other Assets	$116.0K	$119.0K	$122.0K
YoY Change	-20.0%	-16.2%	-13.48%
Total Long-Term Assets	$34.54M	$34.26M	$34.45M
YoY Change	3.94%	5.32%	10.51%
TOTAL ASSETS
Total Short-Term Assets	$124.2M	$126.8M	$126.4M
Total Long-Term Assets	$34.54M	$34.26M	$34.45M
Total Assets	$158.8M	$161.1M	$160.9M
YoY Change	-2.29%	-2.69%	-1.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.800M	$3.180M	$2.534M
YoY Change	11.33%	-4.22%	-23.21%
Accrued Expenses	$1.072M	$1.333M	$1.494M
YoY Change	-23.15%	-16.06%	-12.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.142M	$7.313M	$6.292M
YoY Change	3.21%	-31.45%	-21.28%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.447M	$4.531M	$4.497M
YoY Change	-0.69%	1.93%	1.95%
Total Long-Term Liabilities	$4.447M	$4.531M	$4.497M
YoY Change	-0.69%	1.93%	1.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.142M	$7.313M	$6.292M
Total Long-Term Liabilities	$4.447M	$4.531M	$4.497M
Total Liabilities	$24.72M	$26.41M	$25.26M
YoY Change	-2.21%	-8.11%	-8.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.06M	-$24.90M	-$24.77M
YoY Change	2.84%	2.25%	-1.18%
Common Stock	$2.096M	$2.096M	$2.096M
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$9.156M	$9.397M	$9.397M
YoY Change	-7.88%	-12.94%	-12.94%
Treasury Stock Shares			$506.9K
Shareholders Equity	$134.1M	$134.6M	$135.6M
YoY Change
Total Liabilities & Shareholders Equity	$158.8M	$161.1M	$160.9M
YoY Change	-2.29%	-2.69%	-1.61%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	$1.885M	$1.910M	$1.956M
YoY Change	-6.78%	-30.42%	89.53%
Depreciation, Depletion And Amortization	$261.0K	$260.0K	$331.0K
YoY Change	11.06%	20.37%	18.21%
Cash From Operating Activities	-$1.747M	$44.00K	$4.945M
YoY Change	50.99%	-98.94%	4.55%
INVESTING ACTIVITIES
Capital Expenditures	-$556.0K	$88.00K	-$786.0K
YoY Change	-41.84%	-94.42%	-64.91%
Acquisitions
YoY Change
Other Investing Activities	$3.713M	-$6.388M	-$3.265M
YoY Change	-123.35%	127.01%	-108.74%
Cash From Investing Activities	$3.157M	-$6.476M	-$4.051M
YoY Change	-118.72%	47.48%	-111.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.907M	-$2.046M	-2.043M
YoY Change	20.62%	0.39%	0.64%
NET CHANGE
Cash From Operating Activities	-1.747M	$44.00K	4.945M
Cash From Investing Activities	3.157M	-$6.476M	-4.051M
Cash From Financing Activities	-1.907M	-$2.046M	-2.043M
Net Change In Cash	-497.0K	-$8.478M	-1.149M
YoY Change	-97.46%	269.25%	-103.04%
FREE CASH FLOW
Cash From Operating Activities	-$1.747M	$44.00K	$4.945M
Capital Expenditures	-$556.0K	$88.00K	-$786.0K
Free Cash Flow	-$1.191M	-$44.00K	$5.731M
YoY Change	492.54%	-101.72%	-17.78%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24160000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	24333000	USD
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	190000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	203000	USD
CY2022Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9790000	USD
CY2022Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	9790000	USD
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	119000	USD
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20458210
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	108000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	104000	USD
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2021Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
CY2022Q2	us-gaap	Accrual For Environmental Loss Contingencies AccrualForEnvironmentalLossContingencies	0	USD
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4333000	USD
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	12811000	USD
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	102994000	USD
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	97550000	USD
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8957000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8339000	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	6649000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	4657000	USD
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3862000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3082000	USD
CY2022Q2	us-gaap	Assets Current AssetsCurrent	126795000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	126439000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	122000	USD
CY2022Q2	us-gaap	Assets Assets	161054000	USD
CY2022Q1	us-gaap	Assets Assets	160887000	USD
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3180000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	2534000	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	54000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	53000	USD
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1333000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1494000	USD
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2746000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2211000	USD
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	7313000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6292000	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	163000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	174000	USD
CY2022Q2	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	12621000	USD
CY2022Q1	us-gaap	Accrued Income Taxes Noncurrent AccruedIncomeTaxesNoncurrent	12621000	USD
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1778000	USD
CY2022Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1671000	USD
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4531000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4497000	USD
CY2022Q2	us-gaap	Liabilities Liabilities	26406000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	25255000	USD
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2096000	USD
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	2096000	USD
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169750000	USD
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169665000	USD
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2592000	USD
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3927000	USD
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24903000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24767000	USD
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2898000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1965000	USD
CY2022Q2	pke	Stockolders Equity Including Treasury Stock StockoldersEquityIncludingTreasuryStock	144045000	USD
CY2022Q1	pke	Stockolders Equity Including Treasury Stock StockoldersEquityIncludingTreasuryStock	145029000	USD
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	9397000	USD
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	9397000	USD
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	134648000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	135632000	USD
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	161054000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	160887000	USD
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12783000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13594000	USD
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8691000	USD
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8122000	USD
CY2022Q2	us-gaap	Gross Profit GrossProfit	4092000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	5472000	USD
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1633000	USD
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1648000	USD
CY2022Q2	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2021Q2	us-gaap	Restructuring Charges RestructuringCharges	14000	USD
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	2459000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3810000	USD
CY2022Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	133000	USD
CY2021Q2	us-gaap	Interest And Other Income InterestAndOtherIncome	117000	USD
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	682000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1182000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1910000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	2745000	USD
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20458000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20383000
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20504000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20710000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1910000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	2745000	USD
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-933000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	52000	USD
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	977000	USD
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2797000	USD
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1910000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	2745000	USD
CY2022Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	260000	USD
CY2021Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	216000	USD
CY2022Q2	us-gaap	Share Based Compensation ShareBasedCompensation	85000	USD
CY2021Q2	us-gaap	Share Based Compensation ShareBasedCompensation	64000	USD
CY2022Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	107000	USD
CY2021Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	139000	USD
CY2021Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	294000	USD
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	11000	USD
CY2022Q2	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	2329000	USD
CY2021Q2	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-675000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	44000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	4133000	USD
CY2022Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	88000	USD
CY2021Q2	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1577000	USD
CY2022Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	18962000	USD
CY2021Q2	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	8219000	USD
CY2022Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	12574000	USD
CY2021Q2	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5405000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6476000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4391000	USD
CY2022Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2046000	USD
CY2021Q2	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2038000	USD
CY2022Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2046000	USD
CY2021Q2	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2038000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8478000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2296000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	12811000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41595000	USD
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4333000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39299000	USD
CY2022Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-5000	USD
CY2021Q2	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-95000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	102994000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	97550000	USD
CY2022Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	106964000	USD
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	6000	USD
CY2022Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	3976000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	100241000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	10000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2701000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	64123000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Maturities Rolling Year Two Through Five Fair Value AvailableForSaleSecuritiesDebtMaturitiesRollingYearTwoThroughFiveFairValue	38871000	USD
CY2022Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	102994000	USD
CY2022Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5792000	USD
CY2022Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	4026000	USD
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	350000	USD
CY2022Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	253000	USD
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	507000	USD
CY2022Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	378000	USD
CY2022Q2	us-gaap	Inventory Net InventoryNet	6649000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	4657000	USD
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	15000	USD
CY2022Q2	us-gaap	Operating Lease Payments OperatingLeasePayments	13000	USD
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	190000	USD
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	54000	USD
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	163000	USD
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	217000	USD
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y2M12D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	648300
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.96
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	131600
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.06
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	-0
CY2022Q2	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	-0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	779900
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	12.80
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P5Y8M26D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	471013
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	12.70
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y8M23D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	USD
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	682000	USD
CY2022Q2	pke	Income Tax Expense Benefit Discrete Amount IncomeTaxExpenseBenefitDiscreteAmount	28000	USD
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1182000	USD
CY2021Q2	pke	Income Tax Expense Benefit Discrete Amount IncomeTaxExpenseBenefitDiscreteAmount	143000	USD
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.263	pure
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.300	pure
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1910000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	2745000	USD
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20458000
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20383000
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	46000
CY2021Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	327000
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20504000
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20710000
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2022Q2	pke	Stock Repurchase Program Number Of Additional Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased	1500000
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022Q2	us-gaap	Undistributed Earnings UndistributedEarnings	25000000	USD
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12783000	USD
CY2021Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13594000	USD
CY2022Q2	us-gaap	Noncurrent Assets NoncurrentAssets	34259000	USD
CY2022Q1	us-gaap	Noncurrent Assets NoncurrentAssets	34448000	USD
CY2022Q2	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><em style="font: inherit;">12.</em> CONTINGENCIES</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Litigation</span></i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is subject to a small number of immaterial proceedings, lawsuits and other claims related to environmental, employment, product and other matters. The Company is required to assess the likelihood of any adverse judgments or outcomes in these matters as well as potential ranges of probable losses. A determination of the amount of reserves required, if any, for these contingencies is made after careful analysis of each individual issue. The required reserves <em style="font: inherit;"> may </em>change in the future due to new developments in each matter or changes in approach, such as a change in settlement strategy in dealing with these matters. The Company believes that the ultimate disposition of such proceedings, lawsuits and claims will <em style="font: inherit;">not</em> have a material adverse effect on the liquidity, capital resources, business, consolidated results of operations or financial position of the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i><span style="text-decoration: underline; ">Environmental Contingencies</span></i><i> </i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company and certain of its subsidiaries have been named by the Environmental Protection Agency (the “EPA”) or a comparable state agency under the Comprehensive Environmental Response, Compensation and Liability Act (the “Superfund Act”) or similar state law as potentially responsible parties in connection with alleged releases of hazardous substances at <em style="font: inherit;">three</em> sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Under the Superfund Act and similar state laws, all parties who <em style="font: inherit;"> may </em>have contributed any waste to a hazardous waste disposal site or contaminated area identified by the EPA or comparable state agency <em style="font: inherit;"> may </em>be jointly and severally liable for the cost of cleanup. Generally, these sites are locations at which numerous persons disposed of hazardous waste. In the case of the Company’s subsidiaries, generally the waste was removed from their manufacturing facilities and disposed at waste sites by various companies which contracted with the subsidiaries to provide waste disposal services. Neither the Company nor any of its sub‐sidiaries have been accused of or charged with any wrongdoing or illegal acts in connection with any such sites. The Company believes it maintains an effective and comprehensive environmental compliance program.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The insurance carriers which provided general liability insurance coverage to the Company and its subsidiaries for the years dur‐ing which the Company’s subsidiaries’ waste was disposed at these <em style="font: inherit;">three</em> sites have in the past reimbursed the Company and its subsidiaries for 100% of their legal defense and remediation costs associated with two of these sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company does <span style="-sec-ix-hidden:c85095115">not</span> record environmental liabilities and related legal expenses for which the Company believes that it and its subsidiaries have general liability insurance coverage for the years during which the Company’s subsidiaries’ waste was disposed at <em style="font: inherit;">two</em> sites for which certain subsidiaries of the Company have been named as potentially responsible parties. Pursuant to such general liability insurance coverage, three insurance carriers reimburse the Company and its subsidiaries for <em style="font: inherit;">100%</em> of the legal defense and remediation costs associated with the <em style="font: inherit;">two</em> sites.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Included in selling, general and administrative expenses are charges for actual expenditures and accruals, based on estimates, for certain environmental mat‐ters described above. The Company accrues estimated costs asso‐ciated with known environmental matters when such costs can be reasonably estimated and when the outcome appears probable. The Company believes that the ultimate disposition of known environmental matters will <em style="font: inherit;">not</em> have a material adverse effect on the Company’s results of operations, cash flows or financial position.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p>
CY2022Q2	pke	Percentage Of Legal Defense And Remediation Costs Associated With Sites Reimbursed By Insurance Carriers PercentageOfLegalDefenseAndRemediationCostsAssociatedWithSitesReimbursedByInsuranceCarriers	1	pure
CY2022Q2	pke	Number Of Units Covered Under General Liability Insurance Coverage NumberOfUnitsCoveredUnderGeneralLiabilityInsuranceCoverage	2	pure
CY2022Q2	pke	Number Of Insurance Carriers NumberOfInsuranceCarriers	3	pure

Files In Submission

Name	View Source	Status
0001437749-22-016868-index-headers.html	Edgar Link	pending
0001437749-22-016868-index.html	Edgar Link	pending
0001437749-22-016868.txt	Edgar Link	pending
0001437749-22-016868-xbrl.zip	Edgar Link	pending
ex_390179.htm	Edgar Link	pending
ex_390180.htm	Edgar Link	pending
ex_390181.htm	Edgar Link	pending
ex_390182.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pke-20220529.xsd	Edgar Link	pending
pke-20220529_cal.xml	Edgar Link	unprocessable
pke-20220529_def.xml	Edgar Link	unprocessable
pke-20220529_lab.xml	Edgar Link	unprocessable
pke-20220529_pre.xml	Edgar Link	unprocessable
pke20220529_10q.htm	Edgar Link	pending
pke20220529_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PKE
PARK AEROSPACE CORP Stock $pke

2022 Q3 Form 10-Q Financial Statement

#000143774922016868 Filed on July 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKE PARK AEROSPACE CORP Stock $pke

2022 Q3 Form 10-Q Financial Statement

#000143774922016868 Filed on July 08, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PKE
PARK AEROSPACE CORP Stock $pke